Summary
The rationale for melanoma-specific antitumor agents containing phenolic amines is based in part on the ability of the enzyme tyrosinase to oxidize these prodrugs to toxic intermediates. The phenolic amine compounds 4-S-cysteaminylphenol (4-S-CAP) andN-acetyl-4-S-cysteaminylphenol (N-Ac-4-S-CAP) inhibited in situ thymidylate synthase activity in pigmented melanoma cell lines but had little or no effect on nonpigmented and nonmelanoma cell lines. Theophylline, a cyclic adenosine monophosphate (cAMP) phosphodiesterase inhibitor, increased tyrosinase activity and potentiated the inhibition of in situ thymidylate synthase by N-Ac-4-S-CAP. The inhibition of in situ thymidylate synthase by both drugs in pigmented melanoma cells correlated with the inhibition of DNA synthesis and cell growth and was not due to an indirect effect caused by inhibition of the enzyme dihydrofolate reductase. 4-S-CAP inhibition of thymidylate synthase activity in cell free extracts required oxidation of the drug. In the presence of tyrosinase, the concentration causing a 50% inhibition of thymidylate synthase activity (IC50) in cell-free extacts was <10 μM, but no inhibition was observed in its absence, even at a drug concentration of 500 μM. Two reducing agents, dithioerythritol and glutathione, effectively blocked the inhibition of thymidylate synthase by oxidized 4-S-CAP. In pigmented melanoma cells containing the enzyme tyrosinase, the quinone-mediated mechanism of inhibition of DNA synthesis via inhibition of thymidylate synthase may be uniquely important in the expression of phenolic amine cytotoxicity.
Similar content being viewed by others
References
Alena F, Jimbow K, Ito S (1990) Melanocytotoxicity and antimelanoma effects of phenolic amine compounds in mice in vivo. Cancer Res 50:3743
Balzarini J, De Clerq E (1982) 5-Substituted 2-deoxyuridine: correlation between inhibition of tumor cell growth and inhibition of thymidine kinase and thymidylate synthetase. Biochem Pharmacol 22:3673
Balzarini J, De Clerq E (1984) Strategies for the measurement of the inhibitory effects of thymidine analogs on the inhibitory effects of thymidylate synthetase in intact murine leukemia cells. Biochim Biophys Acta 785:36
Boekelheide K, Graham DG, Mize PD, Koo EH (1980) Melanocytotoxicity and the mechanism of activation of γ-L-glutaminyl-4-hydroxybenzene. J Invest Dermatol 75:322
Cohen SS (1971) On the nature of thymineless death. Ann NY Acad Sci 186:292
Felix CC, Hyde JS, Sarna T, Sealy RC (1978) Melanin photoreactions in aerated media: electron spin resonance evidence for production of superoxide and hydrogen peroxide. Biochem Biophys Res Commun 84:335
Fidler IJ (1975) Biological behaviour of malignant cells correlated to their survival in vivo. Cancer Res 35:1
FitzGerald GB, Wick MM (1986) Sequential inhibitory effects of antitumor agents related to levodopa and dopamine upon DNA synthetic enzymes. Biochem Pharmacol 35:271
Friedkin M (1973) Thymidylate synthetase. Adv Enzymol 38:235
Goulian M, Bleile B, Tsang BY (1980) Methotrexate-induced misincorporation of uracil in DNA. Proc Natl Acad Sci USA 77:1956
Halaban R, Lerner AB (1977) Tyrosinase and inhibition of proliferation of melanoma cells and fibroblasts. Exp Cell Res 108:119
Ingraham HA, Dickey L, Goulian M (1986) DNA fragmentation and cytotoxicity from increased cellular deoxyuridylate. Biochemistry 25:3225
Ito S, Jimbow K (1987) Selective cytotoxicity of 4-S-cysteaminylphenol on follicular melanocytes of the black mouse: rational basis for its application to melanoma chemotherapy. Cancer Res 47:3278
Ito S, Kato T, Ishikawa K, Kasuga T, Jimbow K (1987) Mechanism of selective toxicity of 4-S-cysteinylphenol and 4-S-cysteaminyl-phenol to melanocytes. Biochem Pharmacol 36:2007
Ito S, Kato T, Fujita K (1988) Covalent binding of catechols to proteins through the sulphydryl group. Biochem Pharmacol 37:1707
Jackson RC (1978) The regulation of thymidylate biosynthesis in Novikoff hepatoma cells and the effects of amethopterin, 5-fluorodeoxyuridine and 3-deazauridine. J Biol Chem 253:7440
Kable EPW, Favier D, Parsons PG (1989) Sensitivity of human melanoma cells toL-dopa andD, L-buthionine (S, R)-sulfoximine. Cancer Res 49:2327
Lomax MIS, Greenberg RG (1967) An exchange between the hydrogen atom on carbon 5 of deoxyuridylate and water catalyzed by thymidylate synthetase. J Biol Chem 242:1302
Mead JAR, Vendetti JM, Schrecker AW, Goldin A, Keresztesy JC (1963) The effect of reduced derivatives of folic acid on toxicity and antileukemic effect of methotrexate in mice. Biochem Pharmacol 12:371
Miura S, Ueda T, Jimbow K, Ito S, Fujita K (1987) Synthesis of cysteinylphenol, cysteaminylphenol, and related compounds, and in vivo evaluation of antimelanoma effect. Arch Dermatol Res 279:219
Mojamdar M, Ichihashi I, Mishima Y (1983) Gamma-glutamyl-transpeptidase, tyrosinase, and 5-S-cysteinyldopa in melanoma cells. J Invest Dermatol 81:119
Padgette SR, Herman HH, Han JH, Pollock SH, May SW (1984) Antihypertensive activities of phenylaminoethyl sulfides, a class of synthetic substrates for dopamine B-hydroxylase. J Med Chem 27:1354
Prezioso JA, FitzGerald G, Wick MM (1990) Effects of tyrosinase activity on the cytotoxicity of 3,4-dihydroxybenzylamine and buthionine sulfoximine in human melanoma cells. Pigment Cell Res 3:49
Reddy GPV (1982) Catalytic function of thymidylate synthase is confined to S phase due to its association with replitase. Biochem Biophys Res Commun 109:908
Roberts D (1966) An isotopic assay for thymidylate synthetase. Biochemistry 5:3546
Rode W, Scanlon KJ, Moroson BA, Bertino JR (1980) Regulation of thymidylate synthetase in mouse leukemia cells (L1210). J Biol Chem 255:1305
Sjostrom DA, Forsdyke DR (1974) Isotope-dilution analysis of ratelimiting steps and pools affecting the incorporation of thymidine and deoxycytidine into cultured thymus cells. Biochem J 138:253
Statford IJ, Stephens MA (1989) The differential hypoxic cytotoxicity of bioreductive agents determined in vitro by the MTT assay. Int J Radia Oncol Biol Phys 16:973
Yalowich JC, Kalman TI (1985) Rapid determination of thymidylate synthase activity and its inhibition in intact leukemia cells in vitro. Biochem Pharmacol 34:2319
Yamada I, Seki S, Ito S, Suzuki S, Matsubara O, Kusuga T (1991) The killing effect of 4-S-cysteaminylphenol, a newly synthesized melanin precursor, on B16 melanoma cell lines. Br J Cancer 63:187
Author information
Authors and Affiliations
Additional information
This work was supported in part by a grant from the Claude Worthington Benedum Foundation
Rights and permissions
About this article
Cite this article
Prezioso, J.A., Wang, N. & Bloomer, W.D. Thymidylate synthase as a target enzyme for the melanoma-specific toxicity of 4-S-cysteaminylphenol andN-acetyl-4-S-cysteaminylphenol. Cancer Chemother. Pharmacol. 30, 394–400 (1992). https://doi.org/10.1007/BF00689968
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00689968